Interferon-Gamma Improves Macrophages Function against M. tuberculosis in Multidrug-Resistant Tuberculosis Patients

Area of Science:

• Immunology
• Infectious Diseases
• Cell Biology

Background:

• Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tuberculosis), remains a major global health threat, particularly multidrug-resistant TB (MDR-TB).
• Macrophages play a crucial role in innate immunity against M. tuberculosis via toll-like receptor (TLR) recognition and phagocytosis, and by secreting IL-12 to stimulate T cells for IFN-γ production.
• Defects in innate or adaptive immunity increase susceptibility to M. tuberculosis infection.

Purpose of the Study:

• To investigate the immunopathologic mechanisms in MDR-TB.
• To evaluate the role of recombinant human interferon-gamma (rhIFN-γ) in enhancing macrophage function against M. tuberculosis.

Main Methods:

• Generation of monocyte-derived macrophages (MDMs) from peripheral blood mononuclear cells of MDR-TB patients and healthy controls.
• Assessment of immunologic responses in MDMs using enzyme-linked immunosorbent assay (ELISA) and flow cytometry.

Main Results:

• Macrophages from MDR-TB patients exhibited distinct functional and molecular anomalies.
• A defective immune response to M. tuberculosis was observed in patient-derived MDMs.
• Pretreatment with rhIFN-γ significantly improved the defective immune response of MDMs from MDR-TB patients.

Conclusions:

• rhIFN-γ enhances macrophage function against M. tuberculosis.
• IFN-γ may be a valuable adjuvant therapy for TB patients with poor treatment response, pending further characterization of underlying mechanisms in MDR-TB.